Page last updated: 2024-11-06

mitomycin and Graft vs Host Disease

mitomycin has been researched along with Graft vs Host Disease in 2 studies

Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.

Graft vs Host Disease: The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fast, LD1
DiLeone, G1
Edson, CM1
Purmal, A1
Tokuda, N1
Mayumi, H1
Himeno, K1
Gondo, H1
Fan, JL1
Nomoto, K1

Other Studies

2 other studies available for mitomycin and Graft vs Host Disease

ArticleYear
Inhibition of murine GVHD by PEN110 treatment.
    Transfusion, 2002, Volume: 42, Issue:10

    Topics: Animals; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Cell Division; Crosses, Genetic; Dru

2002
Drug-induced in vitro tolerance to allogeneic antigens. II. Further analysis of in vitro-tolerized spleen cells in a fully allogeneic murine combination.
    Transplantation, 1988, Volume: 45, Issue:2

    Topics: Animals; Animals, Newborn; Crosses, Genetic; Cytotoxicity, Immunologic; Fluorouracil; Graft vs Host

1988